Amgen announces European approval of Prolia

#1 (permalink)

05-29-2010, 03:53 PM

cancerfr

Administrator

Join Date: Sep 2008

Posts: 47,337

Amgen announces European approval of Prolia

Amgen Inc. today announced that the European Commission (EC) has granted marketing authorization for Prolia (denosumab) for the treatment of osteoporosis in postmenopausal women at increased risk of fractures, and for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures.

Tim Pearson

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On Forum Rules

Similar Threads
Thread	Thread Starter	Forum	Replies	Last Post
Amgen's Prolia receives FDA approval for treatment of postmenopausal women with osteo	cancerfr	Pituitary Tumor	0	06-11-2010 06:28 PM
Bone drug from Amgen and Glaxo wins EU approval	cancerfr	Bone Cancer	0	05-29-2010 03:53 PM
Amgen seeks cancer approval for bone loss drug	cancerfr	Lung Cancer	0	05-15-2010 02:24 PM
Amgen seeks cancer approval for bone loss drug	cancerfr	Bone Cancer	0	05-15-2010 02:24 PM

All times are GMT. The time now is 01:04 PM.